Bioengineering applications may be funded by NINDS if they focus on technology development relevant to normal or disordered neural function and to the prevention, repair or replacement of compromised neural function. Funded applications include partnerships that span academic entities (biological, bioengineering, biomedical groups), device industries, commercial distribution companies, medical instrument companies, small business concerns, etc. Final stages of translation for FDA investigational device exemption (IDE) and early-stage clinical trials might be a candidate for one of the NINDS cooperative agreement programs. To search the bioengineering projects funded at NIH please go to NIH RePORTER, or select bioengineering research in the categorical spending. Many of the NINDS funded bioengineering research focuses on neural interfaces, including neuroprostheses, neuromodulation, brain-computer interface (BCI) devices, prosthetic control, and neural interface technology development.
Estimates of Funding for Various Research, Condition, and Disease Categories
|Research/Disease Areas*||FY 2016
*Dollars in millions and rounded
Proceedings & Outcomes
Resources and Tools
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human CNS (UG3/UH3) NS-17-005; (U44 for Small Businesses) NS-17-007
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human CNS (UH3) NS-17-006
News & Events
FDA resources and guidance on Neurological Devices
The BRAIN Initiative webinar series consists of 30 minute presentations from BRAIN-funded investigators developing recording and modulation technologies.